GSK Secures Second Defense Verdict In Illinois Case Alleging Zantac Caused Cancer

(August 7, 2024, 2:46 PM EDT) -- CHICAGO — A Cook County, Ill., jury rejected a woman’s claims that her use of Zantac caused her to be diagnosed with colorectal cancer and returned a verdict in favor of GlaxoSmithKline LLC (GSK), handing the drug manufacturer back-to-back wins in the first two Zantac cases to go to trial....

Attached Documents

Related Sections